公司资料
Oragenics 股价、新闻与催化剂
- 股票代码:
- OGEN
- 交易所:
- AMEX
- 行业:
- Biopharma
- 所在地:
- United States
股票表现
0.48 USD (-2.40%)
收盘价
最后更新: 2026年10月1日
2.75M USD
市值
股价为何变动
截至 2026年10月1日，OGEN 下跌 2.40%，收于 $0.4800。当前新闻监测窗口内未发现新的同公司新闻。
公司概览
业务概览
Oragenics is a biotechnology company focused on infectious disease and central nervous system programs. Its story has long been about using small-cap biotech tools to pursue high-unmet-need therapeutic areas.
所在地与行业分类
Oragenics is headquartered in the United States and listed on NASDAQ. It sits in small-cap biotechnology.
商业模式特征
The company depends on early-stage scientific validation, capital discipline, and the ability to focus its pipeline. Investors watch platform shifts, early data, and financing runway.
生物医药行业定位
Oragenics occupies a speculative small-cap biotech niche. The stock is driven by whether the company can sharpen its thesis enough to sustain investor confidence.
未来催化剂
- Oragenics is a legacy / closeout story, so the catalysts are any remaining strategic or asset-resolution update rather than a live biotech milestone. The market is focused on residual value.
近期新闻
新闻标题由机器翻译，详情为英文原文。
- 01
- 02
- 03
- 04
- 05
相似股票
商业成熟度、治疗领域或催化剂模式相近的同行公司。